{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:26:49Z","timestamp":1790314009316,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1053\/j.seminoncol.2006.12.004","type":"journal-article","created":{"date-parts":[[2007,3,23]],"date-time":"2007-03-23T10:49:19Z","timestamp":1174646959000},"page":"165-172","source":"Crossref","is-referenced-by-count":30,"title":["Immunotherapeutic Strategies for High-Risk Bladder Cancer"],"prefix":"10.1053","volume":"34","author":[{"given":"Padmanee","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd J.","family":"Old","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2006.12.004_bib1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00000441-189305000-00001","article-title":"The treatment of malignant tumors by repeated inoculations of erysipelas","volume":"105","author":"Coley","year":"1893","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/184291a0","article-title":"Effect of Bacillus Calmette-Guerin (B.C.G) infection on transplanted tumours in the mouse","volume":"184","author":"Old","year":"1959","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib5","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1126\/science.285.5428.732","article-title":"Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors","volume":"285","author":"Brightbill","year":"1999","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib6","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1128\/IAI.68.12.6883-6890.2000","article-title":"Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: Involvement of toll-like receptors","volume":"68","author":"Tsuji","year":"2000","journal-title":"Infect Immun"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00941903","article-title":"Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer","volume":"25","author":"de Boer","year":"1997","journal-title":"Urol Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib8","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0022-5347(05)66983-2","article-title":"Urinary interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin","volume":"164","author":"Thalmann","year":"2000","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2249.1995.tb05560.x","article-title":"Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guerin (BCG) immunotherapy","volume":"99","author":"Jackson","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib10","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0022-5347(17)39713-6","article-title":"Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy","volume":"144","author":"Prescott","year":"1990","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib11","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0022-5347(17)45142-1","article-title":"Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG","volume":"136","author":"Haaff","year":"1986","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01741551","article-title":"Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guerin in superficial bladder cancer","volume":"34","author":"De Boer","year":"1992","journal-title":"Cancer Immunol Immunother"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-5347(17)39365-5","article-title":"Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall","volume":"144","author":"Bohle","year":"1990","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00294021","article-title":"Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer","volume":"19","author":"de Boer","year":"1991","journal-title":"Urol Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib15","unstructured":"Sharma P, Jungbluth A, Gnjatic S, et al: CD8+ tumor-infiltrating lymphocytes as a statistically significant marker of disease recurrence and survival in transitional cell carcinoma patients. Proc Natl Acad Sci USA (in press)"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib17","first-page":"3932","article-title":"Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas","volume":"61","author":"Schumacher","year":"2001","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib18","first-page":"3491","article-title":"CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer","volume":"58","author":"Naito","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.imlet.2004.05.011","article-title":"CD45: Direct and indirect government of immune regulation","volume":"94","author":"Huntington","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib20","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1038\/sj.onc.1208074","article-title":"Function of the Src-family kinases, Lck and Fyn, in T cell development and activation","volume":"23","author":"Palacios","year":"2004","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/eji.200324478","article-title":"Phenotypic classification of human CD8+ Tcells reflecting their function: Inverse correlation between correlation between quantitative expression of CD27 and cytotoxic effector function","volume":"34","author":"Tomiyama","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib22","first-page":"293","article-title":"Checkpoint blockade in cancer immunotherapy","volume":"90","author":"Korman","year":"2006","journal-title":"Adv Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/1074-7613(94)90071-X","article-title":"CTLA-4 can function as a negative regulator of T cell activation","volume":"1","author":"Walunas","year":"1994","journal-title":"Immunity"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.182.2.459","article-title":"CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation","volume":"182","author":"Krummel","year":"1995","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1074-7613(00)80406-9","article-title":"Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells","volume":"7","author":"Chambers","year":"1997","journal-title":"Immunity"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","article-title":"Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4","volume":"3","author":"Tivol","year":"1995","journal-title":"Immunity"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib27","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.270.5238.985","article-title":"Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4","volume":"270","author":"Waterhouse","year":"1995","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ni0303-217","article-title":"The nature of molecular recognition by T cells","volume":"4","author":"Davis","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.immunol.19.1.565","article-title":"CTLA-4 mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy","volume":"19","author":"Chambers","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib30","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"van der Bruggen","year":"1991","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1074-7613(95)80053-0","article-title":"BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes","volume":"2","author":"Boel","year":"1995","journal-title":"Immunity"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.182.3.689","article-title":"A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma","volume":"182","author":"Van den Eynde","year":"1995","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib33","doi-asserted-by":"crossref","first-page":"11810","DOI":"10.1073\/pnas.92.25.11810","article-title":"Human neoplasms elicit multiple specific immune responses in the autologous host","volume":"92","author":"Sahin","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib34","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1073\/pnas.94.5.1914","article-title":"A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening","volume":"94","author":"Chen","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib35","first-page":"1","article-title":"The cancer\/testis genes: Review, standardization, and commentary","volume":"4","author":"Scanlan","year":"2004","journal-title":"Cancer Immun"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib36","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.187.8.1349","article-title":"A survey of the humoral immune response of cancer patients to a panel of human tumor antigens","volume":"87","author":"Stockert","year":"1998","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib37","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1073\/pnas.97.9.4760","article-title":"Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses","volume":"97","author":"Jager","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib38","first-page":"4499","article-title":"Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T cell response to the cancer testis antigen NY-ESO-1 in melanoma patients","volume":"60","author":"Valmori","year":"2000","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib39","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1078-0432.CCR-1086-3","article-title":"Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response","volume":"10","author":"Yamaguchi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib40","first-page":"4946","article-title":"NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells","volume":"60","author":"Zarour","year":"2000","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1084\/jem.191.4.625","article-title":"Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma","volume":"191","author":"Jager","year":"2000","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000134734","article-title":"Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28","volume":"79","author":"Chen","year":"1997","journal-title":"Cytogenet Cell Genet"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib43","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/(SICI)1097-0215(19980610)76:6<903::AID-IJC22>3.0.CO;2-1","article-title":"LAGE-1, a new gene with tumor specificity","volume":"76","author":"Lethe","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2051-1426-3-S2-O19","article-title":"Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T cell epitope in a patient with bladder cancer","volume":"3","author":"Sharma","year":"2003","journal-title":"Cancer Immun"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib45","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1158\/1078-0432.CCR-06-0527","article-title":"Cancer testis antigens: Expression and correlation with survival in human urothelial carcinoma","volume":"12","author":"Sharma","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib46","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nm1096-1122","article-title":"DNA-based immunization by in vivo transfection of dendritic cells","volume":"2","author":"Condon","year":"1996","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib47","doi-asserted-by":"crossref","first-page":"8578","DOI":"10.1073\/pnas.93.16.8578","article-title":"Induction of cytotoxic T lymphocytes by intramuscular immunization with plamid DNA is facilitated by bone marrow-derived cells","volume":"93","author":"Doe","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib48","first-page":"23","article-title":"Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide","volume":"7","author":"Nishiyama","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0959-8049(02)00479-3","article-title":"Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: A clinical report","volume":"39","author":"Marchand","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1196\/annals.1309.028","article-title":"CD4+ CD25+ regulatory T cell selection","volume":"1029","author":"Caton","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/86302","article-title":"Thymic selection of CD4+ CD25+ regulatory T cells induced by an agonist self-peptide","volume":"2","author":"Jordan","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib52","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","article-title":"B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ni0103-10","article-title":"Regulatory T cells: Mediating compromises between host and parasite","volume":"4","author":"Sakaguchi","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1034\/j.1600-065X.2001.1820105.x","article-title":"Type I T regulatory cells","volume":"182","author":"Roncarolo","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib55","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.163.10.5211","article-title":"Introduction of tumor immunity by removing CD25+CD4+ T cells: A common basis between tumor immunity and autoimmunity","volume":"163","author":"Shimizu","year":"1999","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib56","first-page":"3128","article-title":"Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody","volume":"59","author":"Onizuka","year":"1999","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib57","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.194.6.823","article-title":"Synergism of cytotoxic T lymphocyte responses","volume":"194","author":"Sutmuller","year":"2001","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib58","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1002\/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1","article-title":"Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens","volume":"32","author":"Golgher","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib59","first-page":"2551","article-title":"Association of increase levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T cell levels in patients with melanoma","volume":"9","author":"Gray","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib60","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","article-title":"Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma","volume":"103","author":"Marshall","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib61","first-page":"4766","article-title":"Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer","volume":"611","author":"Woo","year":"2001","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib62","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.4049\/jimmunol.168.9.4272","article-title":"Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation","volume":"168","author":"Woo","year":"2002","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib63","first-page":"4404","article-title":"Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers","volume":"9","author":"Ichihara","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib64","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.11618","article-title":"CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: Possible involvement of regulatory T cells in disease progression","volume":"98","author":"Sasada","year":"2003","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib65","first-page":"606","article-title":"Increase of regulatory T cells in the peripheral blood of cancer patients","volume":"9","author":"Wolf","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib66","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.169.5.2756","article-title":"Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma","volume":"169","author":"Liyanage","year":"2002","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.164.1.183","article-title":"Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific","volume":"164","author":"Thornton","year":"2000","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib68","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.4049\/jimmunol.169.11.6210","article-title":"Inhibition of human CD4(+)CD25(+high) regulatory T cell function","volume":"169","author":"Baecher-Allan","year":"2002","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib69","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.1078231","article-title":"Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells","volume":"299","author":"Pasare","year":"2003","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib70","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ni1059","article-title":"Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance","volume":"5","author":"Yang","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib71","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib72","first-page":"4036","article-title":"Enhanced induction of antitumor T cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: The effect is manifested only at the restricted tumor-bearing stages","volume":"57","author":"Yang","year":"1997","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib73","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.4049\/jimmunol.167.8.4286","article-title":"Regression of extensive pulmonary metastases in mice by adoptive transfer of antigen-specific CD8+ CTL reactive against tumor cells expressing a naturally occurring rejection epitope","volume":"167","author":"Ryan","year":"2001","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib74","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1084\/jem.190.3.355","volume":"190","author":"van Elsas","year":"1999","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib75","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1084\/jem.194.4.481","article-title":"Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: Comparison of prophylaxis and therapy","volume":"194","author":"van Elsas","year":"2001","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib76","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1073\/pnas.0830997100","article-title":"Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients","volume":"100","author":"Hodi","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2006.12.004_bib77","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1073\/pnas.1533209100","article-title":"Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma","volume":"100","author":"Phan","year":"2003","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775406004817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775406004817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T04:42:36Z","timestamp":1683780156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775406004817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0093775406004817"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2006.12.004","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}